[181]
Multiple myeloma in a patient with fever of unknown origin and ...
[248,9 KB]
From [www.cmaj.ca] Last viewed: 07.09.2006
Living Successfully with Multiple Myeloma
By Peter Tischler
North Texas Myeloma Support Group
by Peter Tischler
I’m not the smartest guy around and, to be honest, I’d guess that many people in our group are smarter than
me. But I’m very good at one thing: I can absorb an enormous amount of data, condense it into a summary,
and communicate the results of that data to other people in such a way that they will understand it. That’s
what I did in business and that’s what I’ve been doing with information about myeloma . Mostly, I do this
one-on-one when people ask for help. This editorial is an attempt to reach a larger audience of people with
our disease.
When I was diagnosed with multiple myeloma (MM) and was led to believe that I would only be around
for a few years, I thought about what I wanted from medical science. I decided that I wanted quality of life
and a chance to ...
[182]
Leukaemia, lymphoma, and multiple myeloma in seamen on tankers
[163,4 KB]
From [oem.bmjjournals.com] Last viewed: 07.09.2006
Living Successfully with Multiple Myeloma
By Peter Tischler
North Texas Myeloma Support Group
by Peter Tischler
I’m not the smartest guy around and, to be honest, I’d guess that many people in our group are smarter than
me. But I’m very good at one thing: I can absorb an enormous amount of data, condense it into a summary,
and communicate the results of that data to other people in such a way that they will understand it. That’s
what I did in business and that’s what I’ve been doing with information about myeloma . Mostly, I do this
one-on-one when people ask for help. This editorial is an attempt to reach a larger audience of people with
our disease.
When I was diagnosed with multiple myeloma (MM) and was led to believe that I would only be around
for a few years, I thought about what I wanted from medical science. I decided that I wanted quality of life
and a chance to ...
[183]
A role of TRAIL in killing osteoblasts by myeloma cells
From [www.fasebj.org] Last viewed: 07.09.2006
Living Successfully with Multiple Myeloma
By Peter Tischler
North Texas Myeloma Support Group
by Peter Tischler
I’m not the smartest guy around and, to be honest, I’d guess that many people in our group are smarter than
me. But I’m very good at one thing: I can absorb an enormous amount of data, condense it into a summary,
and communicate the results of that data to other people in such a way that they will understand it. That’s
what I did in business and that’s what I’ve been doing with information about myeloma . Mostly, I do this
one-on-one when people ask for help. This editorial is an attempt to reach a larger audience of people with
our disease.
When I was diagnosed with multiple myeloma (MM) and was led to believe that I would only be around
for a few years, I thought about what I wanted from medical science. I decided that I wanted quality of life
and a chance to ...
[184]
Multiple myeloma: the death of VAD as initial therapy
[130,6 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[185]
Cancer immunity hits multiple myeloma
[108,0 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[186]
Thrombogenic activity of doxorubicin in myeloma patients receiving ...
[68,7 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[187]
Exciting times for myeloma research “Full length, midi, or mini ...
[169,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[188]
Risky business: Gaucher disease and multiple myeloma
[200,1 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[189]
No RIC in high-risk myeloma?
[125,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[190]
ENDOGENOUS CIRCULATING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING ...
[154,4 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[191]
Myeloma is on the move
[37,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[192]
Newer Approaches to the Therapy of Multiple Myeloma
[221,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[193]
2-CHLORODEOXYADENOSINE FOR MULTIPLE MYELOMA RESPONSE
[164,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[194]
ON THE INFLUENCE OF STILBAMIDINE UPON MYELOMA CELLS IMD, B. mg. In ...
[244,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[195]
PLASMA CELL ACID PHOSPHATASE IN MULTIPLE MYELOMA P
[203,4 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[196]
Constipated myeloma Therapy-related myeloid leukemia: stochastic ...
[565,2 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[197]
A new twist in myeloma treatment
[109,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[198]
Constipated myeloma Therapy-related myeloid leukemia: stochastic ...
[565,2 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[199]
Multiple myeloma: all roads lead to cyclin D
[180,3 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[200]
AMYLASE PRODUCING MULTIPLE MYELOMA
[140,1 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[201]
Global gene expression profiling of multiple myeloma, monoclonal ...
[571,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[202]
A clinically relevant mouse model of human multiple myeloma?
[155,4 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[203]
Osteoblasts make for good neighbors Myeloma: targeted therapies ...
[91,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[204]
ALL in children with Down syndrome Myeloma therapy: the future is ...
[81,9 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[205]
HYPERREACTIVE CELLULAR IMMUNITY MULTIPLE MYELOMA
[189,6 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[206]
Myeloma wrecks T ?
[149,0 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[207]
Toward a rational combinaTORial therapy for multiple myeloma
[380,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[208]
2-CHLORODEOXYADENOSINE IN THE TREATMENT OF MULTIPLE MYELOMA Texas ...
[79,7 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[209]
Therapy of Myeloma
[182,1 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
[210]
APRIL showers cause CLL and myeloma to flower
[51,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor
Growth in Vivo
*
Received for publication,July 25, 2005, and in revised form, September 15, 2005 Published, JBC Papers in Press,September 27, 2005, DOI 10.1074/jbc.M508136200
Yuemeng Dai
‡
, Yang Yang
‡
, Veronica MacLeod
‡
, Xinping Yue
§
, Alan C. Rapraeger
§
, Zachary Shriver
¶
,
Ganesh Venkataraman
¶
, Ram Sasisekharan , and Ralph D. Sanderson
‡1
From the
‡
Department of Pathology and the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little
Rock, Arkansas 72205, the
§
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin
53706,
¶
Momenta Pharmaceuticals, Inc., Cambridge, ...
Found 2056 documents
Page 7 of 69 Pages:
<< < 2 3 4 5 6 7 8 9 10 11 12 > >>
cancers
homepage
last week